TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis

纳米载体 上睑下垂 免疫疗法 宫颈癌 癌症免疫疗法 癌症 癌症研究 医学 肿瘤科 免疫学 内科学 药理学 药品 炎症 炎症体
作者
Huaxi Xu,Danya Zhang,Yu Zhang,Yuxin Chen,Yue Sun,Jie Li,Songwei Tan,Minghao Yin,Rui-Li Wei,Fei Li,Ling Xi
出处
期刊:Theranostics [Ivyspring International Publisher]
卷期号:15 (11): 5420-5439 被引量:1
标识
DOI:10.7150/thno.108357
摘要

Rationale: Pyroptosis, an emerging form of programmed cell death, facilitates the release of tumor antigens and inflammatory factors, which can be leveraged to enhance the efficacy of immune checkpoint blockade (ICB) therapy. However, achieving high-efficiency induction of pyroptosis in cancer cells while minimizing toxicity remains a significant challenge. Methods: In this study, we designed a tumor-targeting peptide TMTP1-modified nanostructured lipid carrier (referred to as TP-NLC) with high loading capacities for gambogic acid (GA) and indocyanine green (ICG). The TMTP1, identified by our research team for its tumor-targeting capabilities, was conjugated to the nanocarrier surface using "click chemistry" to improve the drug delivery efficiency to tumor tissues. The TP-NLC nanocarrier was thoroughly characterized with respect to its morphological attributes, photostability, tumor-targeting capabilities, ability to induce pyroptosis, reactive oxygen species (ROS)-responsive behavior, and anti-tumor efficacy both in vitro and in vivo. Results: GA encapsulated within the TP-NLC nanocarrier, induced pyroptosis in tumor cells, and enhanced the efficacy of ICG-induced pyroptosis under laser irradiation by disrupting intracellular antioxidant systems, realizing that the combination of GA and ICG synergistically induced caspase-3/GSDME-mediated pyroptosis in a ROS-dependent manner. Tumor cells of pyroptosis released cellular contents and tumor antigens, which subsequently promoted the maturation of dendritic cells (DCs), enhanced intratumoral infiltration of CD8+ T cells, initiated systemic antitumor immune response, and augmented the efficiency of PD-1 blockade against both primary and metastatic tumors. Conclusion: The combination of GA and ICG therapy utilizing the constructed nanocarriers presents an attractive therapeutic strategy to trigger pyroptosis and potentiate PD-1 blockade therapy for cervical cancer chemo-immunotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
稳重的如波完成签到 ,获得积分10
刚刚
熟睡的妻子完成签到,获得积分10
1秒前
天天快乐应助Hongyt采纳,获得10
1秒前
乐乐应助久念采纳,获得10
1秒前
葡萄成熟完成签到,获得积分10
1秒前
1秒前
酷波er应助喜喜采纳,获得16
1秒前
小离发布了新的文献求助10
2秒前
益安完成签到,获得积分10
4秒前
TaoTaooooII完成签到,获得积分10
4秒前
rsq完成签到,获得积分10
4秒前
4秒前
麦冬粑粑完成签到,获得积分10
4秒前
Adzuki0812完成签到,获得积分10
5秒前
Kriten完成签到,获得积分10
5秒前
知行合一完成签到,获得积分10
5秒前
6秒前
姜姜完成签到,获得积分10
6秒前
英俊的铭应助霸气的怜珊采纳,获得10
6秒前
爆杀小白鼠完成签到,获得积分10
7秒前
量子星尘发布了新的文献求助10
8秒前
超哥完成签到,获得积分10
8秒前
飞飞完成签到,获得积分10
8秒前
qqwxp完成签到,获得积分10
8秒前
8秒前
婷刘完成签到,获得积分10
8秒前
谦让碧菡完成签到,获得积分10
9秒前
guohuameike完成签到,获得积分10
9秒前
顺利灭绝完成签到,获得积分20
9秒前
单身的乐瑶完成签到,获得积分10
10秒前
Moonchild发布了新的文献求助10
10秒前
萌~Lucky完成签到,获得积分10
11秒前
喜喜完成签到,获得积分20
11秒前
12秒前
12秒前
zgrmws应助科研通管家采纳,获得10
12秒前
顾矜应助科研通管家采纳,获得10
12秒前
fff应助科研通管家采纳,获得10
12秒前
Tengami应助科研通管家采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Binary Alloy Phase Diagrams, 2nd Edition 8000
Building Quantum Computers 800
Translanguaging in Action in English-Medium Classrooms: A Resource Book for Teachers 700
Natural Product Extraction: Principles and Applications 500
Exosomes Pipeline Insight, 2025 500
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5664939
求助须知:如何正确求助?哪些是违规求助? 4873377
关于积分的说明 15110105
捐赠科研通 4823973
什么是DOI,文献DOI怎么找? 2582614
邀请新用户注册赠送积分活动 1536518
关于科研通互助平台的介绍 1495130